VECT — VectivBio Holding AG Cashflow Statement
0.000.00%
Last trade - 00:00
HealthcareAdventurousMid Cap
- $1.06bn
- $846.20m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | -23.5 | -59.9 | -87 | -93.7 |
Depreciation | ||||
Non-Cash Items | 3.46 | 19.1 | 18 | 27.5 |
Other Non-Cash Items | ||||
Changes in Working Capital | 4.97 | 2.39 | -3.39 | 9.77 |
Change in Accounts Receivable | ||||
Change in Other Assets | ||||
Change in Accounts Payable | ||||
Change in Accrued Expenses | ||||
Change in Other Liabilities | ||||
Other Operating Cash Flow | ||||
Cash from Operating Activities | -14.9 | -38.2 | -72.1 | -56.3 |
Capital Expenditures | -0.056 | -0.093 | -0.057 | -0.074 |
Purchase of Fixed Assets | ||||
Other Investing Cash Flow Items | 0.011 | 0.024 | -6.62 | 0 |
Acquisition of Business | ||||
Other Investing Cash Flow | ||||
Cash from Investing Activities | -0.045 | -0.069 | -6.67 | -0.074 |
Financing Cash Flow Items | 0.48 | -1.33 | -12.7 | -13.8 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 32.8 | 56.6 | 141 | 175 |
Foreign Exchange Effects | ||||
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 17.7 | 20.4 | 62.5 | 119 |